PubRank

J S Abrams

Author PubWeight™ 145.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 16.03
2 Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991 6.12
3 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992 5.18
4 Retracted Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol 1990 3.76
5 Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993 3.51
6 Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993 3.04
7 Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol 1992 3.03
8 IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992 2.67
9 T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995 2.57
10 High-dose chemotherapy for breast cancer. Ann Intern Med 1996 2.09
11 Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 1993 2.00
12 Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993 2.00
13 Gamma delta T lymphocytes in human tuberculosis. J Infect Dis 1992 1.78
14 Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999 1.77
15 Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991 1.77
16 The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med 1995 1.74
17 Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993 1.72
18 Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med 1990 1.71
19 Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 1995 1.69
20 Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996 1.68
21 Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 1986 1.60
22 Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods 1993 1.60
23 Increasing incidence of right-sided lesions in colorectal cancer. Am J Surg 1979 1.58
24 High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 1996 1.51
25 A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med 2001 1.48
26 Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 1993 1.47
27 A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. J Clin Oncol 1989 1.46
28 Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun 1993 1.44
29 Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol Med 1995 1.43
30 Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest 1990 1.42
31 IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol 1993 1.39
32 APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol 1999 1.38
33 Expression of murine and human granulocyte-macrophage colony-stimulating factors in S. cerevisiae: mutagenesis of the potential glycosylation sites. EMBO J 1986 1.36
34 Functional heterogeneity among human inducer T cell clones. J Immunol 1988 1.34
35 Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol 1992 1.33
36 Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993 1.31
37 Impingement syndrome in the absence of rotator cuff tear (stages 1 and 2). Orthop Clin North Am 1987 1.30
38 Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis. J Hyg (Lond) 1969 1.29
39 COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science 1989 1.27
40 Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Ann Oncol 2008 1.24
41 The significance of a "positive" rectal examination in acute appendicitis. Dis Colon Rectum 1979 1.24
42 Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 1992 1.18
43 Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun 1994 1.18
44 Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study. J Clin Oncol 1990 1.17
45 Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods 1989 1.17
46 Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991 1.17
47 Induction of human IgE synthesis by CD4+ T cell clones. Requirement for interleukin 4 and low molecular weight B cell growth factor. J Exp Med 1989 1.14
48 Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995 1.13
49 Fractalkine protein localization and gene expression in mouse brain. J Neurosci Res 2003 1.11
50 Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B. J Immunol Methods 1994 1.10
51 Myocardial toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst 1989 1.10
52 Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993 1.09
53 IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993 1.08
54 Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. J Infect Dis 1994 1.08
55 Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 1992 1.07
56 Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 1992 1.06
57 Cancer prognostics: past, present and p27. Nat Med 1997 1.06
58 Tamoxifen: trials, tribulations, and trade-offs. J Natl Cancer Inst 1994 1.05
59 Experimental intestinal atresia. Surgery 1968 1.03
60 Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995 1.02
61 Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest 1992 1.01
62 IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18. J Immunol 2000 1.00
63 Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer. Mol Cell Biol 1989 1.00
64 The absence of a relationship between cholecystectomy and the subsequent occurrence of cancer of the proximal colon. Dis Colon Rectum 1983 1.00
65 Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. Scand J Immunol 1995 1.00
66 Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infect Dis 1993 0.97
67 Acromioplasty for impingement with an intact rotator cuff. J Bone Joint Surg Br 1988 0.93
68 Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. Blood 1991 0.90
69 Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. J Clin Invest 1991 0.88
70 Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994 0.88
71 Factors influencing perineal wound healing after proctectomy. Am J Surg 1983 0.88
72 A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection. J Exp Med 1996 0.87
73 A hard look at colonoscopy. Am J Surg 1977 0.87
74 Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 1991 0.86
75 A second look at colonoscopy: indications, failures, and costs. Arch Surg 1982 0.86
76 Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma. Am J Respir Crit Care Med 1996 0.83
77 Generalized peritonitis due to a ruptured splenic abscess. Am J Surg 1966 0.83
78 In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation. Cell Immunol 1993 0.83
79 A limited sampling strategy for cyclophosphamide pharmacokinetics. Cancer Res 1989 0.82
80 Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol 1991 0.82
81 Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis. J Infect Dis 1993 0.82
82 Similar RANTES levels in healthy and asthmatic airways by immunoassay and in situ hybridization. Am J Respir Crit Care Med 1997 0.81
83 Adverse effects of salt and water retention on pulmonary function in patients with multiple trauma. J Trauma 1973 0.81
84 Effect of phenoxybenzamine on endotoxic shock in dogs. II. Metabolic changes. J Trauma 1969 0.80
85 Augmentation of granulocyte/macrophage colony-stimulating factor expression by ultraviolet irradiation is mediated by interleukin 1 in Pam 212 keratinocytes. J Invest Dermatol 1991 0.79
86 A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat 1991 0.79
87 Chemotherapy for prostatic carcinoma. Semin Urol 1988 0.78
88 Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells. Int Arch Allergy Appl Immunol 1991 0.78
89 Response of the rat to intraperitoneal injection of E. coli endotoxin. J Surg Res 1967 0.78
90 Elective resection for colorectal cancer in Vermont: 1971--1975. Am J Surg 1980 0.78
91 Lymphokine profile in bone marrow transplant recipients. Blood 1991 0.78
92 Compartment syndrome of the upper arm. Orthopedics 1994 0.78
93 Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma. J Natl Cancer Inst 1991 0.78
94 Linkage of interleukin-4 and interleukin-5 production in human helminth infections. Trans Assoc Am Physicians 1991 0.77
95 Tamoxifen: five versus ten years--is the end in sight? J Natl Cancer Inst 2001 0.76
96 Cytokine production at the site of disease in chronic eosinophilic pneumonitis. Am J Respir Crit Care Med 1996 0.76
97 Aftercare of the patient with an ileostomy. Prim Care 1974 0.75
98 Fetal surgery in sheep: technique and results of 53 intrauterine procedures. J Surg Res 1972 0.75
99 Advantages of the problem-oriented medical record in the care of the severely injured patient. J Trauma 1974 0.75
100 Control of Aspergillus fumigatus infection in fetal sheep. Lab Anim Care 1968 0.75
101 Heterogeneity of antigen-specific CD4+ T cell clones from a patient with Schistosomiasis mansoni. Parasite Immunol 1994 0.75
102 Use of standard colon preparation in elective colectomy for carcinoma of the colon. Rev Surg 1977 0.75
103 Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination. J Allergy Clin Immunol 1995 0.75
104 Pulmonary function in patients with multiple trauma and associated severe head injury. J Trauma 1976 0.75
105 Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer. Oncology (Williston Park) 1994 0.75
106 Clinical trials referral resource. Oncology (Williston Park) 1997 0.75
107 Surgical treatment of inflammatory bowel disease of the colon. Ulcerative colitis and granulomatous (Crohn's) colitis. Am J Surg 1975 0.75
108 Effect of phenoxybenzamine on endotoxic shock in dogs. I. Hemodynamic changes. J Trauma 1969 0.75
109 Blood pressure response to the portal infusion of angiotensin-II. Surg Forum 1966 0.75
110 Multiple malignant carcinoids of the stomach. Arch Surg 1980 0.75
111 Clinical staging of rectal cancer. Am J Surg 1980 0.75
112 Clinical trials referral resource. Metastatic breast cancer. Oncology (Williston Park) 1993 0.75
113 Role of steroids in the management of phagedenic ulcer. Surgery 1969 0.75
114 Controlled hypotension for uncontrolled hemorrhage. Arch Surg 1967 0.75
115 Antisense RNA inhibition of hematopoietic growth factor production. Growth Factors 1991 0.75
116 Rapid volume expansion and phenoxybenzamine in endotoxin shock. Surg Forum 1965 0.75
117 CT evaluation of patients during treatment of advanced non-small cell lung carcinoma. Am J Clin Oncol 1986 0.75